Home/Eolo Pharma/María Pia Garat

MP

María Pia Garat

CEO

Therapeutic Areas

Obesity Metabolic Disease Type 2 Diabetes NASH Hypertension ALS Alzheimer's Disease

Eolo Pharma Pipeline

Drug	Indication	Phase
MVD-1 (SANA)	Obesity	Phase 1
Eolo40 NCE	ALS	Discovery
NF-kB inhibitor	Alzheimer's Disease	Discovery

Leadership Team at Eolo Pharma

CSO and Board Member

Carlos Batthyany

View full Eolo Pharma profile